China National Medicines Past Earnings Performance
Past criteria checks 4/6
China National Medicines has been growing earnings at an average annual rate of 9.1%, while the Healthcare industry saw earnings growing at 2% annually. Revenues have been growing at an average rate of 4% per year. China National Medicines's return on equity is 12.6%, and it has net margins of 4.2%.
Key information
9.1%
Earnings growth rate
9.3%
EPS growth rate
| Healthcare Industry Growth | 7.0% |
| Revenue growth rate | 4.0% |
| Return on equity | 12.6% |
| Net Margin | 4.2% |
| Last Earnings Update | 30 Sep 2024 |
Recent past performance updates
Recent updates
We Think China National Medicines (SHSE:600511) Can Manage Its Debt With Ease
Nov 12
The China National Medicines Corporation Ltd. (SHSE:600511) Third-Quarter Results Are Out And Analysts Have Published New Forecasts
Oct 25China National Medicines Corporation Ltd.'s (SHSE:600511) Prospects Need A Boost To Lift Shares
Sep 26Calculating The Fair Value Of China National Medicines Corporation Ltd. (SHSE:600511)
Sep 10Returns On Capital At China National Medicines (SHSE:600511) Paint A Concerning Picture
Jul 28China National Medicines Corporation Ltd.'s (SHSE:600511) Low P/E No Reason For Excitement
Jun 24China National Medicines (SHSE:600511) Has Announced That It Will Be Increasing Its Dividend To CN¥0.854
Jun 07Is China National Medicines (SHSE:600511) Using Too Much Debt?
Jun 05Calculating The Fair Value Of China National Medicines Corporation Ltd. (SHSE:600511)
May 21Capital Allocation Trends At China National Medicines (SHSE:600511) Aren't Ideal
Apr 10China National Medicines (SHSE:600511) Could Easily Take On More Debt
Feb 28Revenue & Expenses Breakdown
How China National Medicines makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 24 | 51,195 | 2,165 | 1,337 | 62 |
| 30 Jun 24 | 50,312 | 2,162 | 1,351 | 66 |
| 31 Mar 24 | 50,592 | 2,191 | 1,417 | 68 |
| 31 Dec 23 | 49,696 | 2,146 | 1,437 | 71 |
| 30 Sep 23 | 47,486 | 1,995 | 1,416 | 76 |
| 30 Jun 23 | 47,632 | 2,086 | 1,476 | 72 |
| 31 Mar 23 | 45,665 | 2,005 | 1,428 | 70 |
| 31 Dec 22 | 45,499 | 1,964 | 1,385 | 67 |
| 30 Sep 22 | 46,719 | 1,884 | 1,413 | 60 |
| 30 Jun 22 | 46,399 | 1,850 | 1,385 | 59 |
| 31 Mar 22 | 47,185 | 1,830 | 1,394 | 57 |
| 31 Dec 21 | 46,469 | 1,754 | 1,390 | 56 |
| 30 Sep 21 | 45,559 | 1,680 | 1,394 | 56 |
| 30 Jun 21 | 44,923 | 1,529 | 1,435 | 55 |
| 31 Mar 21 | 42,512 | 1,449 | 1,445 | 53 |
| 31 Dec 20 | 40,379 | 1,383 | 1,413 | 52 |
| 30 Sep 20 | 41,046 | 1,537 | 1,426 | 62 |
| 30 Jun 20 | 41,153 | 1,469 | 1,418 | 52 |
| 31 Mar 20 | 42,805 | 1,549 | 1,415 | 50 |
| 31 Dec 19 | 44,644 | 1,604 | 1,489 | 45 |
| 30 Sep 19 | 42,673 | 1,525 | 1,443 | 42 |
| 30 Jun 19 | 40,991 | 1,523 | 1,414 | 42 |
| 31 Mar 19 | 39,659 | 1,436 | 1,424 | 37 |
| 31 Dec 18 | 38,740 | 1,404 | 1,457 | 34 |
| 30 Sep 18 | 37,994 | 1,256 | 1,424 | 22 |
| 30 Jun 18 | 37,452 | 1,224 | 1,363 | 30 |
| 31 Mar 18 | 36,653 | 1,163 | 1,176 | 25 |
| 31 Dec 17 | 36,285 | 1,141 | 1,002 | 22 |
| 30 Sep 17 | 36,072 | 1,060 | 918 | 10 |
| 30 Jun 17 | 35,540 | 1,044 | 823 | 0 |
| 31 Mar 17 | 40,103 | 1,101 | 967 | 0 |
| 31 Dec 16 | 34,611 | 990 | 851 | 0 |
| 30 Sep 16 | 28,613 | 887 | 675 | 0 |
| 30 Jun 16 | 22,813 | 752 | 594 | 0 |
| 31 Mar 16 | 12,408 | 527 | 385 | 0 |
| 31 Dec 15 | 12,078 | 513 | 381 | 0 |
| 30 Sep 15 | 12,065 | 499 | 415 | 0 |
| 30 Jun 15 | 11,894 | 499 | 385 | 0 |
| 31 Mar 15 | 11,773 | 490 | 397 | 0 |
| 31 Dec 14 | 11,538 | 483 | 390 | 0 |
| 30 Sep 14 | 11,177 | 465 | 391 | 0 |
| 30 Jun 14 | 10,824 | 457 | 388 | 0 |
| 31 Mar 14 | 10,408 | 431 | 366 | 0 |
| 31 Dec 13 | 10,081 | 412 | 359 | 0 |
Quality Earnings: 600511 has high quality earnings.
Growing Profit Margin: 600511's current net profit margins (4.2%) are higher than last year (4.2%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 600511's earnings have grown by 9.1% per year over the past 5 years.
Accelerating Growth: 600511's earnings growth over the past year (8.5%) is below its 5-year average (9.1% per year).
Earnings vs Industry: 600511 earnings growth over the past year (8.5%) exceeded the Healthcare industry -5.7%.
Return on Equity
High ROE: 600511's Return on Equity (12.6%) is considered low.